Valuable contribution to the evolving future of personalized cardiovascular therapeutics
People older than 35, along with African American, Hispanic, American Indian, and Asian American individuals, have an increased risk of developing prediabetes, too
The study demonstrated clinical improvement across demographics, and patients on a GLP-1 saw -0.9% A1C and a 22% improvement in TIRwith no increase in time in hypoglycemia If you have patients who tell you that they fear lows, that they dont want to give an injection in public, or that MDI is hard, recognize these as the cues they are
The best approach depends on individual goals and lab data
Your provider may also recommend an abdominal assessment if you have a history of gallbladder issues or pancreatitis, as these are relevant safety considerations for GLP-1 therapy